astera labs inc - ALAB
ALAB
Close Chg Chg %
297.84 9.04 3.04%
Closed Market
306.88
+9.04 (3.04%)
Volume: 6.53M
Last Updated:
May 22, 2026, 4:00 PM EDT
Company Overview: astera labs inc - ALAB
ALAB Key Data
| Open $300.00 | Day Range 299.94 - 315.73 |
| 52 Week Range 84.78 - 315.73 | Market Cap $51.05B |
| Shares Outstanding 171.41M | Public Float 138.69M |
| Beta 3.36 | Rev. Per Employee N/A |
| P/E Ratio 200.75 | EPS $1.59 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 6.18M |
ALAB Performance
| 1 Week | 31.89% | ||
| 1 Month | 44.18% | ||
| 3 Months | 136.64% | ||
| 1 Year | 224.33% | ||
| 5 Years | N/A |
ALAB Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
26
Full Ratings ➔
About astera labs inc - ALAB
Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.
ALAB At a Glance
Astera Labs, Inc.
2345 North First Street
San Jose, California 95131
| Phone | 1-408-766-3806 | Revenue | 852.53M | |
| Industry | Semiconductors | Net Income | 219.13M | |
| Sector | Electronic Technology | 2025 Sales Growth | 115.127% | |
| Fiscal Year-end | 12 / 2026 | Employees | 756 | |
| View SEC Filings |
ALAB Valuation
| P/E Current | 200.755 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 136.305 |
| Price to Sales Ratio | 35.037 |
| Price to Book Ratio | 20.762 |
| Price to Cash Flow Ratio | 93.55 |
| Enterprise Value to EBITDA | 159.29 |
| Enterprise Value to Sales | 33.679 |
| Total Debt to Enterprise Value | 0.001 |
ALAB Efficiency
| Revenue/Employee | 1,127,678.571 |
| Income Per Employee | 289,859.788 |
| Receivables Turnover | 10.246 |
| Total Asset Turnover | 0.659 |
ALAB Liquidity
| Current Ratio | 10.238 |
| Quick Ratio | 9.794 |
| Cash Ratio | 8.936 |
ALAB Profitability
| Gross Margin | 75.688 |
| Operating Margin | 20.342 |
| Pretax Margin | 25.589 |
| Net Margin | 25.704 |
| Return on Assets | 16.946 |
| Return on Equity | 18.822 |
| Return on Total Capital | 15.713 |
| Return on Invested Capital | 18.594 |
ALAB Capital Structure
| Total Debt to Total Equity | 2.271 |
| Total Debt to Total Capital | 2.221 |
| Total Debt to Total Assets | 2.022 |
| Long-Term Debt to Equity | 1.967 |
| Long-Term Debt to Total Capital | 1.924 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Astera Labs Inc - ALAB
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 79.87M | 115.79M | 396.29M | 852.52M | |
Sales Growth
| - | +44.97% | +242.24% | +115.13% | |
Cost of Goods Sold (COGS) incl D&A
| 21.19M | 35.97M | 93.59M | 207.26M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 807.00K | 1.78M | 3.15M | 6.83M | |
Depreciation
| - | 1.78M | 3.15M | 6.83M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| - | +69.73% | +160.21% | +121.46% | |
Gross Income
| 58.68M | 79.83M | 302.70M | 645.26M | |
Gross Income Growth
| - | +36.04% | +279.19% | +113.17% | |
Gross Profit Margin
| +73.47% | +68.94% | +76.38% | +75.69% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 118.88M | 109.32M | 418.76M | 471.84M | |
Research & Development
| 73.71M | 73.41M | 200.83M | 304.00M | |
Other SG&A
| 45.16M | 35.92M | 217.94M | 167.84M | |
SGA Growth
| - | -8.03% | +283.05% | +12.67% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | - | - |
EBIT after Unusual Expense
| (60.19M) | (29.50M) | (116.07M) | 173.42M | |
Non Operating Income/Expense
| 2.61M | 6.55M | 34.29M | 44.73M | |
Non-Operating Interest Income
| 2.61M | 6.55M | 34.29M | 44.73M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | - | - |
Interest Expense Growth
| - | - | - | - | - |
Gross Interest Expense
| - | - | - | - | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (57.58M) | (22.95M) | (81.78M) | 218.15M | |
Pretax Income Growth
| - | +60.15% | -256.36% | +366.76% | |
Pretax Margin
| -72.09% | -19.82% | -20.64% | +25.59% | |
Income Tax
| 764.00K | 3.31M | 1.64M | (981.00K) | |
Income Tax - Current - Domestic
| 672.00K | 3.35M | 1.13M | (2.07M) | |
Income Tax - Current - Foreign
| 92.00K | (41.00K) | 510.00K | 1.07M | |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | - | - | 19.00K | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (58.34M) | (26.26M) | (83.42M) | 219.13M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (58.34M) | (26.26M) | (83.42M) | 219.13M | |
Net Income Growth
| - | +55.00% | -217.71% | +362.68% | |
Net Margin Growth
| -73.05% | -22.68% | -21.05% | +25.70% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (58.34M) | (26.26M) | (83.42M) | 219.13M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (58.34M) | (26.26M) | (83.42M) | 219.13M | |
EPS (Basic)
| -0.3753 | -0.1689 | -0.5149 | 1.3168 | |
EPS (Basic) Growth
| - | +55.00% | -204.85% | +355.74% | |
Basic Shares Outstanding
| 155.47M | 155.47M | 162.02M | 166.41M | |
EPS (Diluted)
| -0.3753 | -0.1689 | -0.5149 | 1.2205 | |
EPS (Diluted) Growth
| - | +55.00% | -204.85% | +337.04% | |
Diluted Shares Outstanding
| 155.47M | 155.47M | 162.02M | 179.55M | |
EBITDA
| (59.39M) | (27.72M) | (112.91M) | 180.25M | |
EBITDA Growth
| - | +53.33% | -307.39% | +259.64% | |
EBITDA Margin
| -74.35% | -23.94% | -28.49% | +21.14% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 244.924 | |
| Number of Ratings | 26 | Current Quarters Estimate | 0.69 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 2.973 | |
| Last Quarter’s Earnings | 0.61 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.84 | Next Fiscal Year Estimate | 4.304 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 21 | 21 | 23 | 23 |
| Mean Estimate | 0.69 | 0.79 | 2.97 | 4.30 |
| High Estimates | 0.72 | 0.87 | 3.32 | 7.74 |
| Low Estimate | 0.65 | 0.69 | 2.29 | 3.09 |
| Coefficient of Variance | 2.24 | 6.66 | 7.13 | 22.41 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 17 | 17 | 15 |
| OVERWEIGHT | 2 | 2 | 2 |
| HOLD | 7 | 6 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Astera Labs Inc - ALAB
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Astera Labs Inc - ALAB
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 22, 2026 | Sutter Hill Ventures LLC Director | 7,323 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175 per share | 1,281,525.00 |
| Apr 22, 2026 | Sutter Hill Ventures LLC Director | 336,398 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175.12 per share | 58,910,017.76 |
| Apr 22, 2026 | Sutter Hill Ventures LLC Director | 6,614 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175.12 per share | 1,158,243.68 |
| Apr 22, 2026 | Stefan A. Dyckerhoff Director | 70,901 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175 per share | 12,407,675.00 |
| Apr 22, 2026 | Stefan A. Dyckerhoff Director | 67,144 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175.12 per share | 11,758,257.28 |
| Apr 22, 2026 | Sutter Hill Ventures LLC Director | 345,331 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $175 per share | 60,432,925.00 |
| Feb 20, 2026 | Philip Mazzara General Counsel and Secretary | 138,084 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $126.34 per share | 17,445,532.56 |
| Feb 20, 2026 | Sanjay Gajendra President and COO; Director | 1,540,486 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.66 per share | 192,036,984.76 |
| Feb 20, 2026 | Sanjay Gajendra President and COO; Director | 1,558,601 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $123.93 per share | 193,157,421.93 |
| Feb 20, 2026 | Sanjay Gajendra President and COO; Director | 1,586,784 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $122.84 per share | 194,920,546.56 |
| Feb 20, 2026 | Sanjay Gajendra President and COO; Director | 1,620,431 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $122.16 per share | 197,951,850.96 |
| Feb 20, 2026 | Michael Truett Tate Chief Financial Officer | 192,083 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $126.34 per share | 24,267,766.22 |
| Feb 20, 2026 | Michael Truett Tate Chief Financial Officer | 193,244 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.66 per share | 24,089,797.04 |
| Feb 20, 2026 | Michael Truett Tate Chief Financial Officer | 195,525 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $123.93 per share | 24,231,413.25 |
| Feb 20, 2026 | Michael Truett Tate Chief Financial Officer | 199,081 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $122.84 per share | 24,455,110.04 |
| Feb 20, 2026 | Michael Truett Tate Chief Financial Officer | 203,331 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $122.16 per share | 24,838,914.96 |
| Feb 20, 2026 | Jitendra Mohan Chief Executive Officer; Director | 1,452,739 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $126.34 per share | 183,539,045.26 |
| Feb 20, 2026 | Jitendra Mohan Chief Executive Officer; Director | 1,461,924 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.66 per share | 182,243,445.84 |
| Feb 20, 2026 | Jitendra Mohan Chief Executive Officer; Director | 1,480,039 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $123.93 per share | 183,421,233.27 |
| Feb 20, 2026 | Jitendra Mohan Chief Executive Officer; Director | 1,508,222 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $122.84 per share | 185,269,990.48 |